In mixed hematopoietic chimerism, the donor red cells win - PubMed (original) (raw)
Editorial
In mixed hematopoietic chimerism, the donor red cells win
Matthew M Hsieh et al. Haematologica. 2011 Jan.
No abstract available
Figures
Figure 1.
Comparison of marrow and peripheral blood donor chimerism. Results of two prior studies, along with those of the study by Andreani et al. are summarized here. There were 16 samples of marrow myeloid cells, 13 of marrow erythroid cells, 31 of peripheral blood leukocytes, and 4 of peripheral blood red cells. The error bars refer to standard errors of the mean.
Figure 2.
Erythroid maturation and methods to detect donor cells. Depending on the stage of erythroid differentiation and development, there are specific methods to assay the donor contribution.
Comment on
- Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.
Andreani M, Testi M, Gaziev J, Condello R, Bontadini A, Tazzari PL, Ricci F, De Felice L, Agostini F, Fraboni D, Ferrari G, Battarra M, Troiano M, Sodani P, Lucarelli G. Andreani M, et al. Haematologica. 2011 Jan;96(1):128-33. doi: 10.3324/haematol.2010.031013. Epub 2010 Oct 7. Haematologica. 2011. PMID: 20935000 Free PMC article.
Similar articles
- Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.
Andreani M, Testi M, Gaziev J, Condello R, Bontadini A, Tazzari PL, Ricci F, De Felice L, Agostini F, Fraboni D, Ferrari G, Battarra M, Troiano M, Sodani P, Lucarelli G. Andreani M, et al. Haematologica. 2011 Jan;96(1):128-33. doi: 10.3324/haematol.2010.031013. Epub 2010 Oct 7. Haematologica. 2011. PMID: 20935000 Free PMC article. - Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease.
Abraham A, Hsieh M, Eapen M, Fitzhugh C, Carreras J, Keesler D, Guilcher G, Kamani N, Walters MC, Boelens JJ, Tisdale J, Shenoy S; National Institutes of Health; Center for International Blood and Marrow Transplant Research. Abraham A, et al. Biol Blood Marrow Transplant. 2017 Dec;23(12):2178-2183. doi: 10.1016/j.bbmt.2017.08.038. Epub 2017 Sep 4. Biol Blood Marrow Transplant. 2017. PMID: 28882446 Free PMC article. - Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia.
Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, Roberts IA, Yeager AM, Hsu L, Adamkiewicz T, Kurtzberg J, Vichinsky E, Storer B, Storb R, Sullivan KM; Multicenter Investigation of Bone Marrow Transplantation for Sickle Cell Disease. Walters MC, et al. Biol Blood Marrow Transplant. 2001;7(12):665-73. doi: 10.1053/bbmt.2001.v7.pm11787529. Biol Blood Marrow Transplant. 2001. PMID: 11787529 Clinical Trial. - Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Shenoy S, Angelucci E, Arnold SD, Baker KS, Bhatia M, Bresters D, Dietz AC, De La Fuente J, Duncan C, Gaziev J, King AA, Pulsipher MA, Smith AR, Walters MC. Shenoy S, et al. Biol Blood Marrow Transplant. 2017 Apr;23(4):552-561. doi: 10.1016/j.bbmt.2017.01.009. Epub 2017 Jan 5. Biol Blood Marrow Transplant. 2017. PMID: 28065838 - Allogeneic cellular gene therapy for hemoglobinopathies.
Gaziev J, Lucarelli G. Gaziev J, et al. Hematol Oncol Clin North Am. 2010 Dec;24(6):1145-63. doi: 10.1016/j.hoc.2010.08.004. Epub 2010 Sep 29. Hematol Oncol Clin North Am. 2010. PMID: 21075285 Review.
Cited by
- A Rare Presentation of Acute Kidney Injury in Diffuse Large B-Cell Lymphoma: A Case Report.
Saleh M, Salih N, Kakakhel M, Ullah I, Siraj H, Tariq MN, Ahmad K. Saleh M, et al. Cureus. 2023 Sep 20;15(9):e45642. doi: 10.7759/cureus.45642. eCollection 2023 Sep. Cureus. 2023. PMID: 37868496 Free PMC article. - Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals.
Ho PY, Zhang Z, Hayes ME, Curd A, Dib C, Rayburn M, Tam SN, Srivastava T, Hriniak B, Li XJ, Leonard S, Wang L, Tarighat S, Sim DS, Fiandaca M, Coull JM, Ebens A, Fordyce M, Czechowicz A. Ho PY, et al. Proc Natl Acad Sci U S A. 2021 Nov 9;118(45):e2109175118. doi: 10.1073/pnas.2109175118. Proc Natl Acad Sci U S A. 2021. PMID: 34732575 Free PMC article. - Unmanipulated Stem Cell Boost for Mixed Chimerism in Transfusion Dependent Thalassemia.
Garg A, Shivchhand A, Shah S, Shah K, Patel K, Panchal H, Patel A, Parikh S. Garg A, et al. Indian J Hematol Blood Transfus. 2021 Jul;37(3):458-462. doi: 10.1007/s12288-020-01347-z. Epub 2020 Sep 3. Indian J Hematol Blood Transfus. 2021. PMID: 34267467 Free PMC article. - Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease.
Esrick EB, Lehmann LE, Biffi A, Achebe M, Brendel C, Ciuculescu MF, Daley H, MacKinnon B, Morris E, Federico A, Abriss D, Boardman K, Khelladi R, Shaw K, Negre H, Negre O, Nikiforow S, Ritz J, Pai SY, London WB, Dansereau C, Heeney MM, Armant M, Manis JP, Williams DA. Esrick EB, et al. N Engl J Med. 2021 Jan 21;384(3):205-215. doi: 10.1056/NEJMoa2029392. Epub 2020 Dec 5. N Engl J Med. 2021. PMID: 33283990 Free PMC article. Clinical Trial. - Genome editing of HBG1 and HBG2 to induce fetal hemoglobin.
Métais JY, Doerfler PA, Mayuranathan T, Bauer DE, Fowler SC, Hsieh MM, Katta V, Keriwala S, Lazzarotto CR, Luk K, Neel MD, Perry SS, Peters ST, Porter SN, Ryu BY, Sharma A, Shea D, Tisdale JF, Uchida N, Wolfe SA, Woodard KJ, Wu Y, Yao Y, Zeng J, Pruett-Miller S, Tsai SQ, Weiss MJ. Métais JY, et al. Blood Adv. 2019 Nov 12;3(21):3379-3392. doi: 10.1182/bloodadvances.2019000820. Blood Adv. 2019. PMID: 31698466 Free PMC article.
References
- Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings FT., 3rd Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med. 1984;311(12):780–3. - PubMed
- Thomas ED, Buckner CD, Sanders JE, Papayannopoulou T, Borgna-Pignatti C, De Stefano P, et al. Marrow transplantation for thalassaemia. Lancet. 1982;2(8292):227–9. - PubMed
- Andreani M, Nesci S, Lucarelli G, Tonucci P, Rapa S, Angelucci E, et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant. 2000;25(4):401–4. - PubMed
- Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001;7(12):665–73. - PubMed
- Andreani M, Testi M, Gaziev J, Condello R, Bontadini A, Tazzari PL, et al. Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease. Haematologica. 2011;96(1):128–33. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous